CEBPA and hepatocellular carcinoma: Several studies demonstrated miR-182 involvement in HCC and metastasis, by controlling the expression of genes with tumor suppressor activity, such as the metastasis suppressor MTSS1 [94], Cebpa [95], ephrinA5 [96], and FOXO1 [97].